Literature DB >> 32096147

LncRNA CHRF promotes cell invasion and migration via EMT in gastric cancer.

J Gong1, Y Wang, C Shu.   

Abstract

OBJECTIVE: Long non-coding RNAs (lncRNAs) have been verified to involve in the development and progression of gastric cancer (GC). However, the expression of lncRNA CHRF level in GC has not been mentioned before. Here, we focused on the function of lncRNA CHRF played in GC. PATIENTS AND METHODS: A total of 103 GC tissues and paired para-tumor tissues from GC patients were collected. The quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was applied to measure the lncRNA CHRF level in these samples and GC cell lines. The Wound-healing experiment, transwell assay, and Matrigel assay were employed to study the migration and invasion abilities of GC cells. The underlying molecular of lncRNA CHRF was measured using Western-blot.
RESULTS: LncRNA CHRF expression was significantly higher in 103 GC tissue samples compared with the adjacent para-tumor samples. In GC cells, lncRNA CHRF showed increased expression levels than the human fetal gastric epithelial cells (GES-1). Inhibition of lncRNA CHRF reduced the invasion and migration of MKN-7 cells while the over-expression of lncRNA CHRF promoted HGC-27 cells metastasis. Furthermore, we found that lncRNA CHRF could promote the progression of epithelial-mesenchymal transition (EMT) to promote the GC cell metastasis.
CONCLUSIONS: Our current study demonstrated that lncRNA CHRF functioned as an oncogene in GC and promoted cell invasion and migration via EMT. This might furnish a potential target for the GC biological diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32096147     DOI: 10.26355/eurrev_202002_20168

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Long Non-Coding RNA NCK1-AS1 Serves an Oncogenic Role in Gastric Cancer by Regulating miR-137/NUP43 Axis.

Authors:  Wenxing Li; Jiming Duan; Wenbin Shi; Liqiang Lei; Pin Lv
Journal:  Onco Targets Ther       Date:  2020-10-06       Impact factor: 4.147

2.  LINC01232 Promotes Metastasis and EMT by Regulating miR-506-5p/PAK1 Axis in Gastric Cancer.

Authors:  Gang Chen; Jiangtao Liao; Yan Xu; Yinyun Chen; Juan Li; Guangkui Bu; Qingqing Li
Journal:  Cancer Manag Res       Date:  2022-05-13       Impact factor: 3.602

3.  LINC01272 Promotes Migration and Invasion of Gastric Cancer Cells via EMT.

Authors:  Xue Leng; Geli Liu; Sen Wang; Jing Song; Wanfeng Zhang; Xianqin Zhang; Li Rong; Yongping Ma; Fangzhou Song
Journal:  Onco Targets Ther       Date:  2020-04-22       Impact factor: 4.147

Review 4.  The Impact of Non-coding RNAs in the Epithelial to Mesenchymal Transition.

Authors:  Bashdar Mahmud Hussen; Hamed Shoorei; Mahdi Mohaqiq; Marcel E Dinger; Hazha Jamal Hidayat; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Front Mol Biosci       Date:  2021-03-26

5.  Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma.

Authors:  Chen Jin; Rui Li; Tuo Deng; Jialiang Li; Yan Yang; Haoqi Li; Kaiyu Chen; Huihua Xiong; Gang Chen; Yi Wang
Journal:  Front Mol Biosci       Date:  2021-12-20

6.  Long non-coding RNA CHRF accelerates LPS-induced acute lung injury through microRNA-146a/Notch1 axis.

Authors:  Shu Luo; Xuefeng Ding; Shiqiao Zhao; Tianyi Mou; Ruixiu Li; Xiaoping Cao
Journal:  Ann Transl Med       Date:  2021-08

7.  Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma.

Authors:  Haisu Tao; Yuxin Zhang; Tong Yuan; Jiang Li; Junjie Liu; Yixiao Xiong; Jinghan Zhu; Zhiyong Huang; Ping Wang; Huifang Liang; Erlei Zhang
Journal:  Aging (Albany NY)       Date:  2022-02-11       Impact factor: 5.682

8.  Long non-coding RNA XIST regulates ovarian cancer progression via modulating miR-335/BCL2L2 axis.

Authors:  Qingjuan Meng; Ningning Wang; Guanglan Duan
Journal:  World J Surg Oncol       Date:  2021-06-05       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.